1.
Ndarabu. Trial of Immunotherapy in HIV Patients: Our Experience with the Immuno-Modulator Dithiodinicotinic Acid (CPDS) in 34 Congolese Patients. GJMR [Internet]. 2017 Jan. 15 [cited 2024 May 3];17(K2):19-26. Available from: https://medicalresearchjournal.org/index.php/GJMR/article/view/1291